BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11802612)

  • 1. [Inspection of transfusion sites by the French Blood Establishment].
    Chevrolle F; Hadzlik E; Suchel PL
    Transfus Clin Biol; 2001 Dec; 8(6):485-9. PubMed ID: 11802612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Position of French transfusion operator in the regulation of territorial care in a changing context].
    Thibert JB
    Transfus Clin Biol; 2015; 22(5-6):326-37. PubMed ID: 26603288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The French haemovigilance system.
    Debeir J; Noel L; Aullen J; Frette C; Sari F; Mai MP; Cosson A
    Vox Sang; 1999; 77(2):77-81. PubMed ID: 10516551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Materials surveillance, a surveillance performed on the use of medical devices].
    Canivet N; Hollander K; Mousnier JP; Quaranta JF
    Transfus Clin Biol; 2000 Feb; 7(1):96-100. PubMed ID: 10730351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transfusion medicine in the 2000s, on a reform].
    Hervé P
    Bull Acad Natl Med; 2002; 186(2):379-89; discussion 389-92. PubMed ID: 12145845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research at the Établissement Français du Sang, the French transfusion public service: challenges and responsibilities].
    Tiberghien P
    Transfus Clin Biol; 2014 Nov; 21(4-5):227-8. PubMed ID: 25267202
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quality control of reactant lots at the Nation Blood Group Reference Center (CNRGS). Data for the year 1998].
    Noizat-Pirenne F; Le Pennec PY; Rouger P
    Transfus Clin Biol; 1999 Jun; 6(3):195-200. PubMed ID: 10422213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What is the use of hemovigilance?].
    Quaranta JF; Canivet N
    Transfus Clin Biol; 1998 Dec; 5(6):415-21. PubMed ID: 9894333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative platelet transfusion: recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS) 2003.
    Samama CM; Djoudi R; Lecompte T; Nathan-Denizot N; Schved JF;
    Can J Anaesth; 2005 Jan; 52(1):30-7. PubMed ID: 15625253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management and evolution of French blood establishment (EFS) laboratories' accreditation].
    Trapadoux F; Bouraï D
    Transfus Clin Biol; 2005 Jun; 12(2):103-6. PubMed ID: 15894501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From psychoactive medicines to addictovigilance in French Public Health Code (1990-2017)].
    Baumevieille M; Perri-Plandé J; Miremont-Salamé G; Daveluy A; Haramburu F
    Therapie; 2019 Jun; 74(3):375-382. PubMed ID: 30193805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The revision of the European blood directives: A major challenge for transfusion medicine.
    Folléa G; Aranko K;
    Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tools for improving quality in the transfusion service.
    Berte LM
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S36-42. PubMed ID: 9124228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The French Haemovigilance System: organization and results for 2003.
    Rebibo D; Hauser L; Slimani A; Hervé P; Andreu G
    Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of the implementation of the hemovigilance and transfusion safety system in French hospitals and blood transfusion centers].
    Fialon P; Quaranta JF; Lemonnier MP; Bricard H; Nublat M; Laxenaire MC; Blanloeil Y; Galperine I; Baron JF; Gross S; Fournel JJ; Vezon G; Janvier G
    Transfus Clin Biol; 1998 Jun; 5(3):193-202. PubMed ID: 9691363
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemovigilance: concept, Europe and UK initiatives.
    McClelland B; Love E; Scott S; Williamson LM
    Vox Sang; 1998; 74 Suppl 2():431-9. PubMed ID: 9704478
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood monitoring at the dawn of the 21st century].
    Delbosc A; Weiller J; Dussert P
    Presse Med; 2000 May 27-Jun 3; 29(19):1066-71. PubMed ID: 10874919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conditions for blood components return, after storage in a depot].
    Hervé I; Girard A
    Transfus Clin Biol; 2008 Nov; 15(5):201-4. PubMed ID: 18930688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transfusion in haematology].
    Renaudier P
    Transfus Clin Biol; 2008 Nov; 15(5):228-35. PubMed ID: 18930422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Court of Justice. ECJ 2014/6 Octapharma France SAS v. Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), Ministère des Affaires Sociales et de la Santé, 13 March 2014 (C-512/12).
    Baeyens A; Goffin T
    Eur J Health Law; 2014 Jun; 21(3):317-21. PubMed ID: 25065041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.